Hitachi Bidding to Acquire Wako Pure Chemicals to Strengthen Presence in the Healthcare Sector

The logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg

Hitachi Group has entered the race with Fujifilm to acquire the chemical unit of Takeda Pharmaceuticals, Wako Pure Chemicals Industries. Wako is Japan’s leading supplier of laboratory chemicals for testing compounds in drug development. Takeda, which has 70% stake in Wako, could gain 100 billion yen (US$996 million) if this deal comes through.  Hitachi is bidding to acquire Wako through its chemical unit, Hitachi Chemical, with the intention of strengthening its presence in the healthcare sector. Hitachi may bear some of the acquisition costs.

Read Full News At:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s